Cândida Dias, Erik Keimpema, Rui A Carvalho, Daniela Madeira, Liliana Dias, Ana Ledo, João Laranjinha, Rodrigo A Cunha, Paula Agostinho, Tibor Harkany, Attila Köfalvi
{"title":"Astrocytic GPR55 receptors promote glycolysis.","authors":"Cândida Dias, Erik Keimpema, Rui A Carvalho, Daniela Madeira, Liliana Dias, Ana Ledo, João Laranjinha, Rodrigo A Cunha, Paula Agostinho, Tibor Harkany, Attila Köfalvi","doi":"10.1186/s42238-026-00407-x","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND: The endocannabinoid system is closely associated with systemic and cellular energy metabolism in mammals. We previously demonstrated that the cannabinoid receptors CB1 and CB2 play important roles in cerebral glucose metabolism. GPR55, a paracannabinoid receptor, has been implicated in systemic metabolic regulation and in diseases such as intractable epilepsy, diabetes, and cancer. In the present study, we investigated whether GPR55 also influences brain glucose metabolism. METHODS: Acute hippocampal and cortical slices and primary astrocytic cultures from C57BL/6 mice and Wistar rats were used. Quantitative polymerase chain reaction (qPCR) was used to assess Cnr1 and Gpr55 gene expression levels, and [³H]deoxyglucose/[¹⁴C]-U-glucose uptake assays, high-resolution respirometry using the Oroboros O2k system, and proton nuclear magnetic resonance ([¹H]-NMR) spectroscopy were employed to assess metabolic activity upon receptor activation. RESULTS: qPCR analysis revealed that Cnr1 mRNA dominated in neurons, whereas Gpr55 was predominantly expressed in primary astrocytes. Δ⁹-Tetrahydrocannabinol (Δ⁹-THC), the GPR55-selective synthetic agonist O-1602, the endogenous GPR55 agonists, L-α-lysophosphatidylinositol (LPI) and palmitoylethanolamide (PEA), together with the mixed CB1 receptor antagonist/GPR55 agonist AM251, invariably and significantly stimulated glucose uptake and metabolism in brain preparations at nanomolar concentrations ex vivo. The GPR55-selective antagonist CID16020046 (1 µM) abolished the effects of the GPR55 agonists, as did pretreatment with the cytosolic Ca2+ chelator BAPTA-AM (30 µM). While LPI did not alter oxidative metabolism in either astrocytes or neurons, it selectively stimulated glycolysis and lactate release in astrocytes. CONCLUSIONS: Our findings reveal a novel role for GPR55 in astrocytes. By enhancing glycolytic activity in these cells, GPR55 is likely poised to support, even if indirectly, the energy demands of synaptic transmission. </p>","PeriodicalId":101310,"journal":{"name":"Journal of cannabis research","volume":"8 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13067723/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cannabis research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-026-00407-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: The endocannabinoid system is closely associated with systemic and cellular energy metabolism in mammals. We previously demonstrated that the cannabinoid receptors CB1 and CB2 play important roles in cerebral glucose metabolism. GPR55, a paracannabinoid receptor, has been implicated in systemic metabolic regulation and in diseases such as intractable epilepsy, diabetes, and cancer. In the present study, we investigated whether GPR55 also influences brain glucose metabolism. METHODS: Acute hippocampal and cortical slices and primary astrocytic cultures from C57BL/6 mice and Wistar rats were used. Quantitative polymerase chain reaction (qPCR) was used to assess Cnr1 and Gpr55 gene expression levels, and [³H]deoxyglucose/[¹⁴C]-U-glucose uptake assays, high-resolution respirometry using the Oroboros O2k system, and proton nuclear magnetic resonance ([¹H]-NMR) spectroscopy were employed to assess metabolic activity upon receptor activation. RESULTS: qPCR analysis revealed that Cnr1 mRNA dominated in neurons, whereas Gpr55 was predominantly expressed in primary astrocytes. Δ⁹-Tetrahydrocannabinol (Δ⁹-THC), the GPR55-selective synthetic agonist O-1602, the endogenous GPR55 agonists, L-α-lysophosphatidylinositol (LPI) and palmitoylethanolamide (PEA), together with the mixed CB1 receptor antagonist/GPR55 agonist AM251, invariably and significantly stimulated glucose uptake and metabolism in brain preparations at nanomolar concentrations ex vivo. The GPR55-selective antagonist CID16020046 (1 µM) abolished the effects of the GPR55 agonists, as did pretreatment with the cytosolic Ca2+ chelator BAPTA-AM (30 µM). While LPI did not alter oxidative metabolism in either astrocytes or neurons, it selectively stimulated glycolysis and lactate release in astrocytes. CONCLUSIONS: Our findings reveal a novel role for GPR55 in astrocytes. By enhancing glycolytic activity in these cells, GPR55 is likely poised to support, even if indirectly, the energy demands of synaptic transmission.
背景:内源性大麻素系统与哺乳动物的全身和细胞能量代谢密切相关。我们之前已经证明大麻素受体CB1和CB2在脑葡萄糖代谢中起重要作用。GPR55是一种副大麻素受体,与全身代谢调节和顽固性癫痫、糖尿病和癌症等疾病有关。在本研究中,我们研究了GPR55是否也影响脑葡萄糖代谢。方法:采用C57BL/6小鼠和Wistar大鼠的急性海马和皮质切片和原代星形细胞培养。采用定量聚合酶链反应(qPCR)评估Cnr1和Gpr55基因表达水平,采用[³H]脱氧葡萄糖/[¹⁴C]- u -葡萄糖摄取测定、使用Oroboros O2k系统的高分辨率呼吸测定和质子核磁共振([¹H]-NMR)波谱法评估受体激活后的代谢活性。结果:qPCR分析显示Cnr1 mRNA在神经元中占主导地位,而Gpr55主要在原代星形胶质细胞中表达。Δ⁹-四氢大麻酚(Δ⁹-THC)、GPR55选择性合成激动剂O-1602、内源性GPR55激动剂L-α-溶磷脂酰肌醇(LPI)和棕榈酰乙醇酰胺(PEA),以及混合CB1受体拮抗剂/GPR55激动剂AM251,均在体内以纳米摩尔浓度显著刺激脑制剂中的葡萄糖摄取和代谢。GPR55选择性拮抗剂CID16020046(1µM)消除了GPR55激动剂的作用,细胞质Ca2+螯合剂BAPTA-AM(30µM)预处理也消除了GPR55激动剂的作用。虽然LPI不改变星形胶质细胞或神经元的氧化代谢,但它选择性地刺激星形胶质细胞的糖酵解和乳酸释放。结论:我们的研究结果揭示了GPR55在星形胶质细胞中的新作用。通过增强这些细胞的糖酵解活性,GPR55可能会支持突触传递的能量需求,即使是间接的。